Last updated: 11/07/2018 17:22:46
Flexibility in administration of Arixtra for prevention of symptomatic venous thromboembolism in orthopedic surgery
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Flexibility in administration of Arixtra for prevention of symptomatic venous thromboembolism in orthopedic surgery
Trial description: Flexibility in administration of Arixtra for prevention of symptomatic venous thromboembolism in orthopedic surgery
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Davidson BL et al. FLEXTRA: Early vs Delayed Initiation of Postoperative Fondaparinux Prophylaxis after Joint Replacement: A Clinical Outcome Study. Journal of Thrombosis and Haemostasis 2005;Vol 3, Suppl 1, Abstract OR061
Flexibility In Administration Of Fondaparinux For Prevention Of Symptomatic Venous Thromboembolism In Orthopedic Surgery: The FLEXTRA Trial, Kwong, European Federation of National Associations of Orthopaedics and Traumatology, Lisbon, Portugal, June 4-7, 2005. ( TBD)
Flexibility in administration of Arixtra for prevention of symptomatic VTE in orthopedic surgery, Davidson, American College of Chest Physicians, Seattle, USA, October 23-28, 2004. (oral)
Flexibility in administration of Arixtra for prevention of symptomatic VTE in orthopedic surgery,Colwell, American Association of Hip and Knee Surgeons, Dallas, USA, November 5-7, 2004. (poster)
Medical condition
Thromboembolism
Product
fondaparinux sodium
Collaborators
Not applicable
Study date(s)
September 2002 to January 2004
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2004-21-01
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website